Supporting evidence-based analysis for modified risk tobacco products through a toxicology data-sharing infrastructure

The US FDA defines modified risk tobacco products (MRTPs) as products that aim to reduce harm or the risk of tobacco-related disease associated with commercially marketed tobacco products.  Establishing a product’s potential as an MRTP requires scientific substantiation including toxicity studies an...

Descripción completa

Detalles Bibliográficos
Autores principales: Boué, Stéphanie, Exner, Thomas, Ghosh, Samik, Belcastro, Vincenzo, Dokler, Joh, Page, David, Boda, Akash, Bonjour, Filipe, Hardy, Barry, Vanscheeuwijck, Patrick, Hoeng, Julia, Peitsch, Manuel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000Research 2017
Materias:
Method Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5657032/
https://www.ncbi.nlm.nih.gov/pubmed/29123642
http://dx.doi.org/10.12688/f1000research.10493.2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5657032/
https://www.ncbi.nlm.nih.gov/pubmed/29123642
http://dx.doi.org/10.12688/f1000research.10493.2

Ejemplares similares